SINOVAC LIFE SCIENCES
Sinovac Life Sciences is a research-based company that conducts human vaccine research, development, manufacturing, and sales.
SINOVAC LIFE SCIENCES
Industry:
Biotechnology Life Science Manufacturing
Founded:
2009-01-01
Address:
Beijing, Beijing, China
Country:
China
Status:
Active
Total Funding:
500 M USD
Similar Organizations
Greenlight Biosciences
GreenLight Biosciences is a biotechnology company that develops an RNA platform for agriculture and human health.
Current Employees Featured
Founder
Investors List
Sino Biopharmaceutical
Sino Biopharmaceutical investment in Corporate Round - Sinovac Life Sciences
More informations about "Sinovac Life Sciences"
SINOVAC: Supply Vaccines to Eliminate Human …
SINOVAC Biotech Ltd. ("SINOVAC") is a China-based leading biopharmaceutical company that focuses on the research, development, production, and commercialization of vaccines that protect against human infectious diseases. …See details»
Company-SINOVAC: Supply Vaccines to Eliminate …
Sinovac Biotech Ltd. (SINOVAC) is a China-based biopharmaceutical company that focuses on the R&D, manufacturing, and commercialization of vaccines that protect against human infectious diseases. SINOVAC's product portfolio …See details»
Sinovac Biotech - Wikipedia
Sinovac's commercialized vaccines include CoronaVac (COVID-19 vaccine), Inlive (Enterovirus 71 vaccine), Anflu (influenza vaccine), Healive (hepatitis A vaccine), varicella vaccine and mumps vaccine. CoronaVac is an inactivated virus COVID-19 vaccine developed by Sinovac. It has been in Phase III clinical trials in Brazil, Chile, Indonesia, Philippines, and Turkey. See details»
CoronaVac - Wikipedia
CoronaVac, also known as the Sinovac COVID-19 vaccine, was a whole inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech. It was phase III clinically trialled in Brazil, Chile, Indonesia, the Philippines, and Turkey and relies on traditional technology similar to other inactivated-virus COVID-19 vaccines, such as the Sinopharm BIBP vaccine, a…See details»
The Sinovac-CoronaVac COVID-19 vaccine: What you …
Jun 10, 2022 The available data on the Sinovac-CoronaVac (COVID-19) vaccine in pregnant women are insufficient to assess either vaccine efficacy or possible vaccine-associated risks in pregnancy. However, this vaccine is an inactivated …See details»
Sinovac Life Sciences - Crunchbase Company Profile
Dec 8, 2020 Sub-Organization of . Sinovac Biotech . Founded Date 2009; Founders Weidong Yin; Operating Status Active; ... Company Type For Profit; Phone Number +86-10-8279-9800; Sinovac Life Sciences is a research-based …See details»
China approves Sinovac Biotech COVID-19 vaccine for general …
Feb 6, 2021 Its Beijing-based unit Sinovac Life Sciences is expected to be able to produce over 1 billion doses per year in the form of bulk ingredient by February, it said. ... a World Health …See details»
Immunogenicity, safety and consistency of seven lots of an …
Jan 5, 2024 CoronaVac, an inactivated COVID-19 vaccine, was developed by Sinovac Life Sciences Co., Ltd. (hereafter referred to as Sinovac) beginning in early 2020. Extensive …See details»
WHO validates Sinovac COVID-19 vaccine for emergency use and …
Jun 1, 2021 WHO today validated the Sinovac-CoronaVac COVID-19 vaccine for emergency use, giving countries, funders, procuring agencies and communities the assurance that it …See details»
Covid-19: China’s CoronaVac vaccine offers 83.5
Jul 9, 2021 Two doses of the new CoronaVac vaccine made in China have an efficacy of 83.5% against symptomatic covid-19, an interim analysis has shown.1 The vaccine, developed by the Chinese company Sinovac Life Sciences and …See details»
Efficacy, immunogenicity and safety of CoronaVac® in children …
Aug 6, 2024 CoronaVac® is an inactivated COVID-19 vaccine developed by Sinovac Life Sciences Co., Ltd. ... 2021S00157) and was approved by the World Health Organization for …See details»
Real-world effectiveness and factors associated with effectiveness …
Apr 27, 2023 Several SARS-CoV-2 vaccines have received World Health Organization (WHO) Emergency Use Listing , including two China-produced inactivated vaccines, BBIBP-CorV (by …See details»
CoronaVac: more data for regulators and policy makers
Jul 17, 2021 Inactivated viral vaccines are an established technology and have several advantages for large-scale roll-out, including their stability at normal refrigeration temperatures …See details»
World Health Organization authorizes China’s Sinovac Covid-19
Jun 1, 2021 The World Health Organization (WHO) has authorized a Covid-19 vaccine made by Chinese pharmaceutical company Sinovac for emergency use. The decision will allow …See details»
Background document on the inactivated vaccine Sinovac …
Jun 1, 2021 This background document on the Sinovac-CoronaVac vaccine was prepared by the Working Group on COVID-19 Vaccines of the Strategic Advisory Group of Experts (SAGE) …See details»
Lot-to-lot consistency, immunogenicity, and safety of an …
The COVID-19 Vaccine (Vero Cell), Inactivated (hereinafter referred to as “CoronaVac”), was developed by Sinovac Life Sciences Co., Ltd. (hereinafter referred to as “SINOVAC”). …See details»
Efficacy and safety of an inactivated whole-virion SARS ... - The …
Jul 17, 2021 Sinovac Life Sciences provided the investigational products and reviewed the data and final manuscript before submission; however, the authors retained editorial control. …See details»
FACT SHEET FOR HEALTH WORKERS - apps.who.int
FACT SHEET FOR HEALTH WORKERS Sinovac-CoronaVac COVID-19 vaccine 1. GENERAL INFORMATION Vaccine name: Sinovac-CoronaVac Vaccine platform: Inactivated whole virus …See details»
Safety, tolerability, and immunogenicity of an inactivated SARS …
Nov 17, 2020 CoronaVac (Sinovac Life Sciences, Beijing, China) is an inactivated vaccine candidate against COVID-19 that has shown good immunogenicity in mice, rats, and non …See details»
World Health Organization Authorizes SINOVACs ... - World …
SINOVAC Biotech Ltd., a leading provider of biopharmaceutical products in China, announced that CoronaVac®, an innovative, inactivated coronavirus vaccine developed by SINOVAC Life …See details»